Skip to main content
OpenTrials
Completed

NCT Number: NCT02330471

Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial

In a randomized clinical trial of 120 women undergoing large loop excision of the transformation zone (LLETZ)-conization for cervical dysplasia, two coagulation modes, spray versus forced coagulation, will be compared. The primary outcome of the study is time to complete hemostasis, secondary outcomes are intraoperative blood loss, postoperative pain, and postoperative bleeding complications.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Ruhr University Bochum

Bochum, 44625, Germany

About this study

Intraoperative bleeding during large loop excision of the transformation zone (LLETZ)-conization can be achieved by two modes of electrocoagulation, spray coagulation and forced coagulation. Spray coagulation is a superficial coagulation mode, whereas forced coagulation is a deep tissue coagulation mode. It is unknown, whether spray or forced coagulation is superior regarding intraoperative hemostasis and other outcome Parameters such as postoperative bleeding and postoperative pain. Therefore, the investigator designed a randomized clinical trial of 120 women undergoing large loop excision of the transformation zone (LLETZ)-conization for cervical dysplasia, comparing the two coagulation modes, spray coagulation and forced coagulation, The primary outcome of the study is time to complete hemostasis measured in seconds, secondary outcomes are intraoperative blood loss measured as difference in serum hemoglobin pre- and postoperatively, postoperative pain according to a 10 step VAS scale, and postoperative bleeding complications, defined as necessity to intervene surgically for vaginal bleeding up to 14 days postoperatively. The study Population consists of women undergoing LLETZ-conization for histologically proven cervical dysplasia. The study hypothesis states that the difference in the mean time until complete hemostais will be at least 1/3 shorter in women randomized to spray coagulation. With a study Population of 120 women, this study has a power of >80% to detect a difference of 1/3 of the mean coagulation time until complete hemostais based on an anticipated mean time of 85 seconds.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • histologically proven cervical dysplasia
  • colposcopy Prior to LLETZ-conization
  • informed consent
  • no known hematologic disorder

Exclusion criteria

  • significant language barrier
  • a personal history of LLETZ-conization

Treatment and study plan

Spray

Procedure

surgical method to achieve intraoperative hemostasis by a superficial electrocoagulation of 80 Watt voltage

Forced

Procedure

surgical method to achieve intraoperative hemostasis by a deep tissue electrocoagulation of 80 Watt voltage

Primary outcomes

  1. time to complete intraoperative hemostasis

    Time frame: 120 seconds

    the time until complete hemostasis as judged by the surgeon has been achieved, will be measured in seconds

Secondary outcomes

  1. postoperative pain

    Time frame: 5 hours

    patients will score their postoperative pain Level using a 10-step visual analogue scale (VAS) within 5 hours after surgery

  2. postoperative complications

    Time frame: 14 days

    postoperative complications defined as the necessity to intervene surgically for vaginal bleeding within 14 days after surgery

  3. intraoperative blood loss

    Time frame: 5 hours

    intraoperative blood loss will be measured using the difference in serum hemoglobin one day prior to surgery and within 5 hours postoperatively

Sponsors and collaborators

Lead sponsor

Ruhr University of Bochum

Other

Registry information

Acronym: CONE-1

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jan 5, 2015
Registry last updated
Jul 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.